Request / Find a Test Tool

The National Genomic Test Directories specify which genomic tests are commissioned by the NHS in England, to be delivered by Genomic Laboratory Hubs.

This tool allows clinical teams to search all of the genomic tests available to patients through the National Testing Directory. From here you can find out more details about each test and information about how to order them. These tests can only be ordered by clinical teams, if you are a patient looking to request a test please speak to your clinical team directly.

Thyroid Papillary Carcinoma – Adult

Clinical Indication ID & Name

M9

Thyroid Papillary Carcinoma - Adult

Test Group

Solid Tumours (Adult)

Specialties

Test code

M9.1

Test name

Multi-target NGS panel - small variant (BRAF, KRAS, NRAS, HRAS, TERT promoter)

Target genes

BRAF, KRAS, NRAS, HRAS, TERT promoter

Test scope

Small variant detection

Test method/ technology

Panel

Optimal Family Structure

n/a

Eligibility Criteria

Molecular assessment will aid diagnosis or management. Molecular assessment of TERT promoter will aid prognosis.

Test code

M9.2

Test name

Multi-target NGS panel - structural variant (RET, NTRK1, NTRK2, NTRK3)

Target genes

RET, NTRK1, NTRK2, NTRK3

Test scope

Structural variant detection

Test method/ technology

Panel

Optimal Family Structure

n/a

Eligibility Criteria

Molecular assessment will aid diagnosis or management / Patient’s clinical status means they are eligible for an NTRK inhibitor in the event an NTRK rearrangement is detected

Test code

M9.3

Test name

RET rearrangement FISH/RT-PC

Target genes

RET

Test scope

Structural variant detection

Test method/ technology

FISH

Optimal Family Structure

n/a

Eligibility Criteria

Molecular assessment will aid diagnosis or management

Test code

M9.4

Test name

Multi-target NGS panel - structural variant (NTRK1, NTRK2, NTRK3)

Target genes

NTRK1, NTRK2, NTRK3

Test scope

Structural variant detection

Test method/ technology

Panel

Optimal Family Structure

n/a

Eligibility Criteria

Patient’s clinical status means they are eligible for an NTRK inhibitor in the event an NTRK rearrangement is detected

Test code

M9.6

Test name

TERT promoter hotspot

Target genes

TERT promoter

Test scope

Small variant detection

Test method/ technology

Simple targeted mutation testing

Optimal Family Structure

n/a

Eligibility Criteria

In rare cases where this cannot be delivered by panel testing NB will be subject to close audit. Molecular assessment will aid prognosis

Commissioning group

n/a

Overlapping idications

n/a

Address for samples/request forms

North Thames GLH, Rare & Inherited Disease Genomic Laboratory
Specimen Reception, Level 5 Barclay House, 37 Queen Square,
London WC1N 3BH

Contact with queries

rmh-tr.moleculardiagnostics@nhs.net

Supporting documents

Cancer WGS Clinician pack

Education resources

n/a

Service updates

n/a

Request form download

Solid Tumour Request Form

Consent record

See consent guidance in test request form

Sample requirements

See sample guidance in test request form